2015 Vol.33, N°5 - Suppl.93 - Table of contents

Psoriatic Arthritis

Guest Editors: T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

purchase complete issue

Introduction

CER9050
2015,33,5,Suppl.93
Pg. 0001

Free to view

Psoriatic arthritis
T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

Skin and nail manifestations in psoriatic arthritis

CER8924
2015,33,5,Suppl.93
Pg. 0002-0006

Free to view

Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine
W. Alwan, F.O. Nestle

CER8922
2015,33,5,Suppl.93
Pg. 0007-0013

Free to view

Nail psoriasis
R. Manhart, P. Rich

CER9009
2015,33,5,Suppl.93
Pg. 0014-0019

Free to view

The skin in psoriasis: assessment and challenges
V. Oji, T.A. Luger

Musculoskeletal manifestations of psoriatic arthritis

CER9008
2015,33,5,Suppl.93
Pg. 0020-0025

Free to view

The joint in psoriatic arthritis
M. Mortezavi, R. Thiele, C. Ritchlin

CER8901
2015,33,5,Suppl.93
Pg. 0026-0030

Free to view

Peripheral joint involvement in psoriatic arthritis patients
M.L. Acosta Felquer, O. Fitzgerald

CER8882
2015,33,5,Suppl.93
Pg. 0031-0035

Free to view

The involvement of the spine in psoriatic arthritis
X. Baraliakos, L.C. Coates, J. Braun

CER8920
2015,33,5,Suppl.93
Pg. 0036-0039

Free to view

The enthesis in psoriatic arthritis
D. Mcgonagle, A.L. Tan

CER8986
2015,33,5,Suppl.93
Pg. 0040-0043

Free to view

The conundrum of juvenile psoriatic arthritis
A. Ravelli, A. Consolaro, B. Schiappapietra, A. Martini

Assessment of psoriatic arthritis

CER8878
2015,33,5,Suppl.93
Pg. 0044-0047

Free to view

Assessment of disease activity in psoriatic arthritis
P.S. Helliwell

CER8891
2015,33,5,Suppl.93
Pg. 0048-0050

Free to view

Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review
J.S. Smolen, M. Schoels, D. Aletaha

CER8865
2015,33,5,Suppl.93
Pg. 0051-0054

Free to view

An overview of low disease activity and remission in psoriatic arthritis
E. Lubrano, F.M. Perrotta, A. Kavanaugh

Imaging in psoriatic arthritis

CER8971
2015,33,5,Suppl.93
Pg. 0055-0059

Free to view

Radiographic scoring methods in psoriatic arthritis
S. Wassenberg

CER8820
2015,33,5,Suppl.93
Pg. 0060-0065

Free to view

Psoriatic arthritis: what ultrasound can provide us
A. Delle Sedie, L. Riente

CER8781
2015,33,5,Suppl.93
Pg. 0066-0069

Free to view

Magnetic resonance imaging for diagnosing, monitoring and prognostication in psoriatic arthritis
R.P. Poggenborg, I.J. Sørensen, S.J. Pedersen, M. Østergaard

Approach to therapy of psoriatic arthritis

CER8877
2015,33,5,Suppl.93
Pg. 0070-0072

Free to view

Therapy strategies in psoriatic arthritis
L.C. Coates

CER8886
2015,33,5,Suppl.93
Pg. 0073-0077

Free to view

Treatment of psoriatic arthritis: management recommendations
L. Gossec, J.S. Smolen

CER8923
2015,33,5,Suppl.93
Pg. 0078-0081

Free to view

Skin therapies: dermatologic perspective on the rheumatology-dermatology interface
J.L. Sasaki, J.Y. Koo

CER9016
2015,33,5,Suppl.93
Pg. 0082-0093

Free to view

Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
T. Pincus, M.J. Bergman, Y. Yazici

Targeted systemic DMARDs in psoriatic arthritis

CER8987
2015,33,5,Suppl.93
Pg. 0094-0097

Free to view

The role of methotrexate in psoriatic arthritis: what is the evidence?
I. Ianculescu, M.H. Weisman

CER9003
2015,33,5,Suppl.93
Pg. 0098-0100

Free to view

Apremilast in psoriatic arthritis
G. Schett

CER8995
2015,33,5,Suppl.93
Pg. 0101-0103

Free to view

Cyclosporine in psoriatic arthropathy
A. Soriano, N. Pipitone, C. Salvarani

Biological agents in psoriatic arthritis

CER9000
2015,33,5,Suppl.93
Pg. 0104-0108

Free to view

A short history of biological therapy for psoriatic arthritis
P. Mease

CER8956
2015,33,5,Suppl.93
Pg. 0109-0114

Free to view

Anti-TNFα-therapy as an evidence-based treatment option for different clinical manifestations of psoriatic arthritis
M. Köhm, H. Burkhardt, F. Behrens

CER8919
2015,33,5,Suppl.93
Pg. 0115-0118

Free to view

Interleukin-12 and interleukin-23 inhibition in psoriatic arthritis
H.J. Johnsson, I.B. Mcinnes

CER8879
2015,33,5,Suppl.93
Pg. 0119-0123

Free to view

Interleukin-17 inhibition in psoriatic arthritis
T. Boyd, A. Kavanaugh

Continuing Medical Education Activity

CER9138
2015,33,5,Suppl.93
Pg. 0124-0126

Free to view

Continuing Medical Education Evaluation
No Author